Double uterus-hemivagina-renal agenesis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3411OMIM:192050Q51.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Double uterus-hemivagina-renal agenesis syndrome, also known as Herlyn-Werner-Wunderlich (HWW) syndrome or obstructed hemivagina and ipsilateral renal anomaly (OHVIRA), is a rare congenital malformation involving the Müllerian (paramesonephric) and Wolffian (mesonephric) duct systems. It is characterized by a triad of findings: uterus didelphys (double uterus), obstructed hemivagina (typically caused by a longitudinal vaginal septum), and ipsilateral renal agenesis (absence of one kidney on the same side as the vaginal obstruction). These three features arise from a developmental defect during embryogenesis affecting the coordinated development of the reproductive and urinary tracts. The condition predominantly affects females and is often diagnosed around the time of puberty (menarche), when menstrual blood accumulates behind the obstructed hemivagina, forming a hematocolpos. Patients typically present with progressive pelvic pain, a pelvic mass, dysmenorrhea, or abnormal vaginal discharge that may become foul-smelling if secondary infection occurs. Some patients may also develop hematometra (blood accumulation in the uterus) or endometriosis due to retrograde menstruation. Renal agenesis is usually asymptomatic and may be discovered incidentally during imaging for the gynecological symptoms. Diagnosis is established through imaging modalities such as pelvic ultrasound, MRI, and sometimes hysteroscopy or laparoscopy. Treatment is primarily surgical and involves excision or marsupialization of the obstructing vaginal septum to allow drainage of the obstructed hemivagina. This procedure is generally curative for the obstructive symptoms and has excellent outcomes. Following appropriate surgical management, most patients retain normal menstrual function and have favorable reproductive potential, although they may face a higher risk of obstetric complications related to the uterine anomaly. Long-term follow-up is recommended to monitor for potential complications including endometriosis and to provide appropriate obstetric counseling.

Also known as:

Clinical phenotype terms— hover any for plain English:

Breech presentationHP:0001623Uterus didelphysHP:0003762Partial vaginal septumHP:0008670Chronic painHP:0012532Abnormal uterine cervix morphologyHP:0012888DyspareuniaHP:0030016HydrocolposHP:0030711DysmenorrheaHP:0100607MetrorrhagiaHP:0100608
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Double uterus-hemivagina-renal agenesis syndrome.

View clinical trials →

No actively recruiting trials found for Double uterus-hemivagina-renal agenesis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Double uterus-hemivagina-renal agenesis syndrome community →

No specialists are currently listed for Double uterus-hemivagina-renal agenesis syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Double uterus-hemivagina-renal agenesis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Double uterus-hemivagina-renal agenesis syndromeForum →

No community posts yet. Be the first to share your experience with Double uterus-hemivagina-renal agenesis syndrome.

Start the conversation →

Latest news about Double uterus-hemivagina-renal agenesis syndrome

No recent news articles for Double uterus-hemivagina-renal agenesis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Double uterus-hemivagina-renal agenesis syndrome

What is Double uterus-hemivagina-renal agenesis syndrome?

Double uterus-hemivagina-renal agenesis syndrome, also known as Herlyn-Werner-Wunderlich (HWW) syndrome or obstructed hemivagina and ipsilateral renal anomaly (OHVIRA), is a rare congenital malformation involving the Müllerian (paramesonephric) and Wolffian (mesonephric) duct systems. It is characterized by a triad of findings: uterus didelphys (double uterus), obstructed hemivagina (typically caused by a longitudinal vaginal septum), and ipsilateral renal agenesis (absence of one kidney on the same side as the vaginal obstruction). These three features arise from a developmental defect during

How is Double uterus-hemivagina-renal agenesis syndrome inherited?

Double uterus-hemivagina-renal agenesis syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Double uterus-hemivagina-renal agenesis syndrome typically begin?

Typical onset of Double uterus-hemivagina-renal agenesis syndrome is juvenile. Age of onset can vary across affected individuals.